April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Next-Generation Sequencing of a 40-Mb Region Reveals Tspan12 Mutations in Patients With Autosomal Dominant Familial Exudative Vitreoretinopathy
Author Affiliations & Notes
  • K. Nikopoulos
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • C. Gilissen
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • A. Hoischen
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • C. E. van Nouhuys
    Ophthalmology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands
  • F. N. Boonstra
    Bartiméus Institute for the Visually Impaired, Zeist, The Netherlands
  • H. Scheffer
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • L. H. Hoefsloot
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • J. A. Veltman
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • F. P. M. Cremers
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • R. W. J. Collin
    Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6349. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Nikopoulos, C. Gilissen, A. Hoischen, C. E. van Nouhuys, F. N. Boonstra, H. Scheffer, L. H. Hoefsloot, J. A. Veltman, F. P. M. Cremers, R. W. J. Collin; Next-Generation Sequencing of a 40-Mb Region Reveals Tspan12 Mutations in Patients With Autosomal Dominant Familial Exudative Vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6349.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To date, mutations in three genes (FZD4, LRP5 and NDP) have been shown to cause familial exudative vitreoretinopathy (FEVR). The purpose of this study was to determine the genetic defect in 11 families with autosomal dominant FEVR that do not carry mutations in the known FEVR genes.

Methods: : Individuals from two large Dutch pedigrees were genotyped using genome-wide SNP arrays, revealing a novel locus for FEVR. Targeted array-based sequence capture combined with next-generation sequencing was applied in the proband of one family, by analyzing all exons and intron-exon boundaries of 338 genes, together with all microRNAs and highly conserved genomic regions in this novel locus.

Results: : Genome-wide SNP analysis in two FEVR families identified a novel 40-Mb FEVR locus on chromosome 7, and subsequent microsatellite marker analysis suggested similar at risk haplotypes in patients of both families. Next-generation sequencing detected the p.A237P variant in the transmembrane 4 superfamily member 12 protein, encoded by TSPAN12. Sanger sequencing of 10 additional unrelated FEVR families identified the same missense mutation in 4 of them, together with one additional mutation (p.G188R) in one other family.

Conclusions: : We have identified TSPAN12 as a novel causative gene for adFEVR, being only the third autosomal gene described for this disease and mutated in five out of eleven Dutch families without FZD4 and LRP5 mutations. The protein has very recently been implicated in regulating the development of retinal vasculature, together with FZD4, LRP5 and NDP. Moreover, we have proven as one of the first groups ever, the enormous potential of next generation sequencing technology combined with array-based sequence capture, by identifying a single causative base-pair substitution within a 40-Mb region containing more than 300 genes.

Keywords: gene mapping • genetics • mutations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×